Compounds > losartan

losartan and dimethylnitrosamine

losartan has been researched along with dimethylnitrosamine in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (80.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ1
Ekins, S; Williams, AJ; Xu, JJ1
Bhalla, V; Byrd, JB; Chertow, GM1
Schmidt, AH; Schmidtsdorff, S1
de Lima, PC; Maranho, RLDN; Marques, FFC; Monteiro, MA; Novotny, TS; Ochs, SM; Vaz, FAS1

Other Studies

5 other study(ies) available for losartan and dimethylnitrosamine

ArticleYear
Developing structure-activity relationships for the prediction of hepatotoxicity.
    Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes

2010
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010
Hypertension Hot Potato - Anatomy of the Angiotensin-Receptor Blocker Recalls.
    The New England journal of medicine, 2019, Apr-25, Volume: 380, Issue:17

    Topics: Angiotensin II Type 1 Receptor Blockers; Dimethylnitrosamine; Drug Contamination; Drug Recalls; Humans; Hypertension; Irbesartan; Losartan; Nitrosamines; United States; United States Food and Drug Administration; Valsartan

2019
Simultaneous detection of nitrosamines and other sartan-related impurities in active pharmaceutical ingredients by supercritical fluid chromatography.
    Journal of pharmaceutical and biomedical analysis, 2019, Sep-10, Volume: 174

    Topics: Angiotensin II Type 1 Receptor Blockers; Chromatography, Supercritical Fluid; Diethylnitrosamine; Dimethylnitrosamine; Drug Contamination; Limit of Detection; Losartan; Nitrosamines; Propylamines; Quality Control; Reference Standards; Risk Assessment; Valsartan

2019
Thymol-Based Hydrophobic Deep Eutectic Solvents as a Green Approach for Screening Polar Nitrosamines in Sartans Pharmaceutical Products by Ultrasound-Assisted Dispersive Liquid-Liquid Microextraction Combined with HPLC-DAD.
    Journal of pharmaceutical sciences, 2023, Volume: 112, Issue:5

    Topics: Angiotensin II Type 1 Receptor Blockers; Chromatography, High Pressure Liquid; Deep Eutectic Solvents; Dimethylnitrosamine; Limit of Detection; Liquid Phase Microextraction; Losartan; Nitrosamines; Pharmaceutical Preparations; Solvents; Thymol

2023